Relecura Makes Patent Innovation Research Platform Free to Coronavirus Researchers in Wake of Pandemic
ncarol.com/10051865

PLEASANTON, Calif. - ncarol.com -- Relecura Inc., a leading provider of AI-powered patent and scientific innovation research,  today announced that Coronavirus researchers across the globe who are working on discovering a solution to the crisis will have free access to its premium research platform until May 31, 2020. Using Relecura's premium research platform, researchers can find and build on existing IP and patent research that will aid them in finding solutions to the current COVID-19 world pandemic.

Interested researchers are invited to take advantage of this unique opportunity by emailing their name, title, work email and company name to researcher@relecura.com.

"The solution to the current crisis we're facing lies in the hands of researchers. Giving them access to the vast amount of existing technical knowledge that is available and the tools to process it to gain greater insight is our way of helping them help us," said George Koomullil, founder of Relecura Inc. "It's also a small way for us to demonstrate our thanks."

Relecura has published two research reports on Coronavirus to assist the research community. The first report, titled Coronavirus Patent Landscape, studies patents related to Coronavirus remedies and provides insights into patent data ranging from antigens and chemotherapeutics to gene therapy and supportive medication. On the other hand, Technical Exploration on Coronavirus explores topics related to Coronaviruses using the technical search engine Tech Explorer.

More on ncarol.com

• Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
• Charlotte-based PR Founder + Expert Launches New Website Highlighting Brand Astrology™ Methodology
• Just 1 in 57 Crypto Owners Globally Pay Taxes on Their Holdings, New Report Finds
• IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
• AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)

About Relecura:

Relecura Inc is a software product company based in the San Francisco Bay Area. It's subsidiary, Relecura Technologies Pvt. Ltd., is in Bangalore. The company's full-stack cognitive cloud platform aids in managing strategic decisions by drawing powerful insights from patents and scientific literature using artificial intelligence, machine learning and natural language processing. Relecura's enterprise platform integrates the discovery and analysis of public documents with internal company documents, and thus builds a single knowledge base for organization-wide usage. Relecura has an API to help create custom tools for IP and business intelligence. For more details visit www.relecura.com.